Developer docs
API playgroundTry for free, no card

Search company profiles

Institute for Systems Biology

Full company profile

uuid0003dej

Namestring
Institute for Systems Biology
Legal namestring
Institute for Systems Biology (ISB)
Company typeenum
Private
Founded yearint
2000
Descriptiontext

The Institute for Systems Biology (ISB) is a nonprofit biomedical research organization founded in 2000 and headquartered in Seattle's South Lake Union district. ISB applies systems biology — integrating molecular biology, genetics, software engineering, microbial ecology, and computational biology — to understand and treat complex diseases across five primary research areas: cancer, health (including microbiome science), infectious disease, chronic illness, and environment. The organization serves the global scientific research community, academic and research institutions, and students/trainees through a combination of open-source research outputs and specialized laboratory services.

ISB's core technology portfolio includes MICOM (an open-source microbial community-scale metabolic modeling tool), the unified Dfam and Repbase transposable element databases, and advanced single-cell bacterial analysis capabilities developed in the Kuchina Lab. Fee-for-service offerings include Olink Services and Proteomics Services built around mass spectrometry-based protein analysis. The institute also operates education programs such as postdoctoral fellowships, student internships, and symposia.

The business model is typical of a mid-sized nonprofit research institute: the majority of funding comes from government grants (a $13M NCI grant was disclosed in 2022) and philanthropic donations (supported by formal giving priority areas including the Mary E. Brunkow Fund, HPV+ Cancer, My Digital Gut, STEM Education, and a Postdoctoral Fellowship Fund), supplemented by fee-for-service proteomics work performed for external academic and research clients. Distribution is direct and global, relying on scientific publications, open-source software ecosystems, symposia, and a coordinated social media presence across LinkedIn, Bluesky, X, Instagram, Facebook, and YouTube.

Short descriptiontext

The Institute for Systems Biology is a Seattle-based nonprofit research organization that applies systems biology — integrating molecular biology, computational biology, and engineering — to understand complex diseases and serves the global scientific research community through open-source tools and fee-for-service proteomics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
systems biology research, proteomics services, open-source scientific software, microbiome research, biomedical research training
Industry3 codes
1Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
CodeHLAGAJACPrimaryYes
2Knowledge Management & Scientific Collaboration / Literature Intelligence
CodeHLAGAJANPrimaryNo
3Proteomics & Mass Spectrometry Services
CodeHLAGANABPrimaryNo
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Biomedical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research Services
TypeProfessional Services
Description

Olink Services and Proteomics Services offered to researchers and institutions, providing fee-for-service laboratory analysis

isbscience.org
2Grants and Donations
TypeSubscription Recurring
Description

Funding from government agencies, foundations, and individual donors supporting research programs

isbscience.org
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Institute for Systems Biology is a non-profit biomedical research organization that conducts systems-level research in cancer, microbiome science, infectious disease, chronic illness, and environmental biology. It complements its research program with fee-for-service proteomics laboratory work (Olink and mass spectrometry), maintenance of widely adopted open-source scientific software (MICOM, Dfam, Repbase), and a pipeline of education programs for students, postdoctoral fellows, and visiting scholars.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Institute for Systems Biology is a nonprofit scientific research organization offering a portfolio of open-source software tools and research services. Core offerings include MICOM (microbial community-scale metabolic modeling software), the Dfam and Repbase databases (unified for transposable element research), and specialized proteomics services via Olink technology and mass spectrometry. The organization also provides educational programs including postdoctoral fellowships, student programs, and courses. These products and services support cross-disciplinary research in cancer, microbiome/health, infectious disease, chronic illness, and environment.

Product and service5 records
1MICOM
CategoryOpen-source scientific software
Description

Open-source Python software for simulating microbial community metabolism using genome-scale models, used by computational biology researchers worldwide.

2Proteomics Services
CategoryLaboratory services
Description

Fee-for-service mass spectrometry-based proteomics laboratory service delivering quantitative protein measurements to academic and industry researchers.

3Olink Service
CategoryLaboratory services
Description

Service offering proximity extension assay (PEA) protein analysis on the Olink platform for high-multiplex biomarker profiling, available to academic and industry clients.

4Dfam
CategoryOpen-source scientific database
Description

Open-source database and toolkit for transposable element annotation and curation, used by genomics researchers worldwide.

5Repbase
CategoryReference database with licensed access
Description

Curated reference database of repetitive DNA sequences used for genome annotation, available to academic users and through commercial licensing for industry users.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Dfam and Repbase Collaboration
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

The Dfam and Repbase collaboration unifies decades of expert curation with open infrastructure to accelerate genome annotation and genomics research. This new collaboration makes the complete Repbase collection openly available through Dfam, creating a unified resource for transposable element research. This partnership advances open science in genome annotation.

isbscience.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Seattle-based nonprofit scientific research organization operating large-scale, open-science programs across brain, cell, and immunology. Closely comparable to ISB in nonprofit model, Seattle footprint, open-science philosophy, and interdisciplinary team structure.

TypeBroad incumbent
Description

MIT/Harvard-affiliated nonprofit biomedical and genomic research organization. Directly comparable as a multi-program systems biology and genomics research institute with significant open-source software output and large-scale federal grant funding.

TypeOthers
Description

Primary federal funder of cancer research in the U.S., including a $13M grant to ISB in 2022. Comparable as a counterparty in the funding ecosystem and a benchmark for the scale and priorities of translational cancer research ISB pursues.

TypeEmerging player
Description

Commercial proteomics platform company offering deep, unbiased proteomic profiling. Comparable as a participant in the proteomics services ecosystem that ISB competes with via its Proteomics Services offering.

TypeBroad incumbent
Description

U.S. Department of Energy national laboratory with globally recognized proteomics and mass spectrometry capabilities. Comparable in advanced proteomics research infrastructure and biological systems science, though funded by DOE rather than NIH.

TypeDirect peer
Description

Nonprofit biomedical research organization with strengths in immunology, structural biology, and chemistry. Comparable in nonprofit research model, federal funding base, and training programs (graduate and postdoctoral).

TypeDirect peer
Description

Independent nonprofit biological research institute conducting fundamental research in cancer, neuroscience, immunology, and plant biology. Comparable as a peer nonprofit research organization with similar funding mix and translational ambition.

TypeDirect peer
Description

Intergovernmental bioinformatics institute hosting major open genomic databases (Ensembl, UniProt). Comparable in stewardship of foundational open-access biological databases and genome annotation resources analogous to Dfam/Repbase.

TypeRegional player
Description

Seattle-based nonprofit cancer research and treatment center. Comparable as a peer Seattle-area research institute with overlapping immunology and oncology research, large federal grants (NCI), and translational research programs.

TypeBroad incumbent
Description

NIH division operating major open genomic and biomedical databases (GenBank, PubMed, dbGaP). Comparable as a steward of foundational open scientific data infrastructure used across the biomedical community.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Institute for Systems Biology

Biomedical Research Servicessystemsbiology.org

The Institute for Systems Biology is a Seattle-based nonprofit research organization that applies systems biology — integrating molecular biology, computational biology, and engineering — to understand complex diseases and serves the global scientific research community through open-source tools and fee-for-service proteomics.

What Institute for Systems Biology does

The Institute for Systems Biology (ISB) is a nonprofit biomedical research organization founded in 2000 and headquartered in Seattle's South Lake Union district. ISB applies systems biology — integrating molecular biology, genetics, software engineering, microbial ecology, and computational biology — to understand and treat complex diseases across five primary research areas: cancer, health (including microbiome science), infectious disease, chronic illness, and environment. The organization serves the global scientific research community, academic and research institutions, and students/trainees through a combination of open-source research outputs and specialized laboratory services.

ISB's core technology portfolio includes MICOM (an open-source microbial community-scale metabolic modeling tool), the unified Dfam and Repbase transposable element databases, and advanced single-cell bacterial analysis capabilities developed in the Kuchina Lab. Fee-for-service offerings include Olink Services and Proteomics Services built around mass spectrometry-based protein analysis. The institute also operates education programs such as postdoctoral fellowships, student internships, and symposia.

The business model is typical of a mid-sized nonprofit research institute: the majority of funding comes from government grants (a $13M NCI grant was disclosed in 2022) and philanthropic donations (supported by formal giving priority areas including the Mary E. Brunkow Fund, HPV+ Cancer, My Digital Gut, STEM Education, and a Postdoctoral Fellowship Fund), supplemented by fee-for-service proteomics work performed for external academic and research clients. Distribution is direct and global, relying on scientific publications, open-source software ecosystems, symposia, and a coordinated social media presence across LinkedIn, Bluesky, X, Instagram, Facebook, and YouTube.

Institute for Systems Biology firmographics

Firmographics
Name
Institute for Systems Biology
Legal name
Institute for Systems Biology (ISB)
Website
https://systemsbiology.org
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
501–1,000 employees
Short description
The Institute for Systems Biology is a Seattle-based nonprofit research organization that applies systems biology — integrating molecular biology, computational biology, and engineering — to understand complex diseases and serves the global scientific research community through open-source tools and fee-for-service proteomics.
Ownership category
akta.pro rank

Institute for Systems Biology industry classification

Industry
Product category
Biomedical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro primary industry
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
akta.pro secondary industries
Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Proteomics & Mass Spectrometry Services (HLAGANAB)

Keywords

  • Systems biology research
  • Proteomics services
  • Open-source scientific software
  • Microbiome research
  • Biomedical research training

Where Institute for Systems Biology is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Institute for Systems Biology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Research Services: Olink Services and Proteomics Services offered to researchers and institutions, providing fee-for-service laboratory analysis
  2. Grants and Donations: Funding from government agencies, foundations, and individual donors supporting research programs

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Institute for Systems Biology product offering

Product offering

Core offering

The Institute for Systems Biology is a non-profit biomedical research organization that conducts systems-level research in cancer, microbiome science, infectious disease, chronic illness, and environmental biology. It complements its research program with fee-for-service proteomics laboratory work (Olink and mass spectrometry), maintenance of widely adopted open-source scientific software (MICOM, Dfam, Repbase), and a pipeline of education programs for students, postdoctoral fellows, and visiting scholars.

Product overview

The Institute for Systems Biology is a nonprofit scientific research organization offering a portfolio of open-source software tools and research services. Core offerings include MICOM (microbial community-scale metabolic modeling software), the Dfam and Repbase databases (unified for transposable element research), and specialized proteomics services via Olink technology and mass spectrometry. The organization also provides educational programs including postdoctoral fellowships, student programs, and courses. These products and services support cross-disciplinary research in cancer, microbiome/health, infectious disease, chronic illness, and environment.

Differentiator

Problem solved

Functional benefit

Products and services

  • MICOM Open-source Python software for simulating microbial community metabolism using genome-scale models, used by computational biology researchers worldwide.
  • Proteomics Services Fee-for-service mass spectrometry-based proteomics laboratory service delivering quantitative protein measurements to academic and industry researchers.
  • Olink Service Service offering proximity extension assay (PEA) protein analysis on the Olink platform for high-multiplex biomarker profiling, available to academic and industry clients.
  • Dfam Open-source database and toolkit for transposable element annotation and curation, used by genomics researchers worldwide.
  • Repbase Curated reference database of repetitive DNA sequences used for genome annotation, available to academic users and through commercial licensing for industry users.

Companies that use Institute for Systems Biology

Customer profile

Segments3 records

Ideal customer profiles3 records

Institute for Systems Biology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Institute for Systems Biology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Dfam and Repbase CollaborationcoreStrategic or Co-development Partner · 26 June 2026The Dfam and Repbase collaboration unifies decades of expert curation with open infrastructure to accelerate genome annotation and genomics research. This new collaboration makes the complete Repbase collection openly available through Dfam, creating a unified resource for transposable element research. This partnership advances open science in genome annotation.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Institute for Systems Biology competitors and assessment

Company assessment

Direct peers

  • Allen Institute: Seattle-based nonprofit scientific research organization operating large-scale, open-science programs across brain, cell, and immunology. Closely comparable to ISB in nonprofit model, Seattle footprint, open-science philosophy, and interdisciplinary team structure.
  • Scripps Research: Nonprofit biomedical research organization with strengths in immunology, structural biology, and chemistry. Comparable in nonprofit research model, federal funding base, and training programs (graduate and postdoctoral).
  • Salk Institute for Biological Studies: Independent nonprofit biological research institute conducting fundamental research in cancer, neuroscience, immunology, and plant biology. Comparable as a peer nonprofit research organization with similar funding mix and translational ambition.
  • European Bioinformatics Institute (EMBL-EBI): Intergovernmental bioinformatics institute hosting major open genomic databases (Ensembl, UniProt). Comparable in stewardship of foundational open-access biological databases and genome annotation resources analogous to Dfam/Repbase.

Broad incumbents

  • Broad Institute: MIT/Harvard-affiliated nonprofit biomedical and genomic research organization. Directly comparable as a multi-program systems biology and genomics research institute with significant open-source software output and large-scale federal grant funding.
  • Pacific Northwest National Laboratory (PNNL): U.S. Department of Energy national laboratory with globally recognized proteomics and mass spectrometry capabilities. Comparable in advanced proteomics research infrastructure and biological systems science, though funded by DOE rather than NIH.
  • National Center for Biotechnology Information (NCBI/NIH): NIH division operating major open genomic and biomedical databases (GenBank, PubMed, dbGaP). Comparable as a steward of foundational open scientific data infrastructure used across the biomedical community.

Others

  • National Cancer Institute (NCI): Primary federal funder of cancer research in the U.S., including a $13M grant to ISB in 2022. Comparable as a counterparty in the funding ecosystem and a benchmark for the scale and priorities of translational cancer research ISB pursues.

Emerging players

  • Seer, Inc. Commercial proteomics platform company offering deep, unbiased proteomic profiling. Comparable as a participant in the proteomics services ecosystem that ISB competes with via its Proteomics Services offering.

Regional players

  • Fred Hutchinson Cancer Center: Seattle-based nonprofit cancer research and treatment center. Comparable as a peer Seattle-area research institute with overlapping immunology and oncology research, large federal grants (NCI), and translational research programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Institute for Systems Biology social profiles

Digital presence

Institute for Systems Biology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Institute for Systems Biology leadership team

Management profile

Number of profiles

Profiles5 records

Institute for Systems Biology funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Institute for Systems Biology M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Systems Biology

What does Institute for Systems Biology do?

The Institute for Systems Biology is a non-profit biomedical research organization that conducts systems-level research in cancer, microbiome science, infectious disease, chronic illness, and environmental biology. It complements its research program with fee-for-service proteomics laboratory work (Olink and mass spectrometry), maintenance of widely adopted open-source scientific software (MICOM, Dfam, Repbase), and a pipeline of education programs for students, postdoctoral fellows, and visiting scholars.

Is Institute for Systems Biology a public or private company?

Institute for Systems Biology is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Institute for Systems Biology founded?

Institute for Systems Biology was founded in 2000. It employs 501 to 1,000 people.

Where is Institute for Systems Biology based?

Institute for Systems Biology is headquartered in Seattle, United States, in the North America region.

How does Institute for Systems Biology make money?

Two revenue lines are on record. Research Services are the primary driver. The others are grants and Donations.

Who are Institute for Systems Biology's main competitors?

Direct peers on record are Allen Institute, Scripps Research, Salk Institute for Biological Studies and European Bioinformatics Institute (EMBL-EBI). Broad incumbents are Broad Institute, Pacific Northwest National Laboratory (PNNL) and National Center for Biotechnology Information (NCBI/NIH). National Cancer Institute (NCI) is listed as an others. Seer, Inc. is listed as an emerging player. Fred Hutchinson Cancer Center is listed as a regional player.

Does Institute for Systems Biology have an API?

No public API is recorded for Institute for Systems Biology.

What industry is Institute for Systems Biology in?

Institute for Systems Biology's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GenengnewsMolecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection IdentifiedResearchers at the Institute for Systems Biology, led by Jim Heath, identified atypical memory B cells, especially DN2 cells, as the precursors of autoantibody-producing cells in SARS-CoV-2 infection, using single-cell RNA sequencing, chromatin profiling, proteomics and genetic analyses. DN2 cells showed TLR7 pathway enrichment and enrichment of autoimmune disease heritability, and autoantibody levels inversely correlated with neutralizing IgG. Findings were published in Immunity.Mirage NewsISB Finds Immune Cells Behind COVID-19 AutoantibodiesResearchers at the Institute for Systems Biology, led by Dr. Jim Heath, published in Immunity a study identifying atypical memory B cells, particularly DN2 cells, as the source of autoantibodies produced after SARS-CoV-2 infection. The team combined single-cell RNA sequencing, chromatin profiling, proteomics and genetic analyses, finding DN2 cells enriched for autoimmune disease risk and activated TLR7, T-bet and XBP1 pathways.ScienceAlertYour Poop Schedule Says a Lot About Your Overall Health, Study RevealsA 2024 study led by the Institute for Systems Biology (ISB) found that bowel movement frequency is linked to specific health markers and potential chronic disease risks in generally healthy individuals. The research identified a 'Goldilocks zone' of one to two daily movements associated with optimal health, while deviations were correlated with liver damage biomarkers or kidney-damaging toxins. These findings suggest that managing bowel habits through diet and microbiome shifts could optimize overall wellness.GeekWireSeattle scientists Mary Brunkow and Fred Ramsdell win Nobel Prize for immunology researchMary Brunkow of the Institute for Systems Biology and Fred Ramsdell of Sonoma Biotherapeutics won the 2025 Nobel Prize in Physiology or Medicine for their research on immune cells that prevent autoimmune diseases. Their work alongside Shimon Sakaguchi has significantly advanced the understanding of the immune system and launched a new field in peripheral tolerance research. This research has implications for developing therapies targeting cancer and autoimmune diseases.NewsTranslator for biomedical research aims to speed up patient careNIH's National Center for Advancing Translational Sciences awarded Penn State researchers $2.57 million for fiscal year 2025, with an anticipated total of $12.8M over five years, to lead a 24-researcher team in expanding and improving the NIH Biomedical Data Translator—a network that helps accelerate drug discovery by providing fact-based answers to biomedical research questions. The project aims to enhance the Translator system to function like an AI question-and-answer agent with traceable, provenance-backed answers, ultimately lowering barriers for clinicians and researchers to access and use the tool for rare disease research. The team includes researchers from Penn State, Oregon State University, Institute of Systems Biology, Broad Institute of MIT and Harvard, and Université Grenoble Alpes in France.BBC Science Focus MagazineHere’s what your pooping frequency says about your healthResearchers from the Institute for Systems Biology in the USA identified a 'Goldilocks Zone' of one to two bowel movements per day as optimal for health, linking this frequency to a gut microbiome that produces beneficial short-chain fatty acids. The study of 1,400 adults found that constipation and diarrhoea are associated with harmful protein fermentation byproducts linked to kidney and liver damage respectively. These findings suggest that monitoring bowel movement frequency could help identify early signs of organ damage and chronic disease risks.FrontiersA data-driven approach to improve wellness and reduce recurrence in cancer survivorsThis perspective article proposes a data-driven methodology aimed at enhancing wellness and reducing cancer recurrence among survivors. The authors, affiliated with academic institutions and biotechnology companies, outline a framework leveraging systems biology and artificial intelligence for personalized health management.ScientificamericanUsing Data to Live Longer, Healthier LivesThe Institute for Systems Biology and its spin-off company Arivale have pioneered a "scientific wellness" approach that utilizes multiomic data, such as genomics and proteomics, combined with behavioral coaching to prevent disease. A pilot study involving 108 participants demonstrated that this data-driven method could identify early health risks and drive significant clinical improvements through personalized lifestyle interventions.GeekWireInstitute for Systems Biology awarded $13M to study administering cancer drugs in successionThe National Cancer Institute has awarded Seattle's Institute for Systems Biology $13 million to lead a collaborative cancer center study of targeted therapies and immunotherapies. Researchers will use mouse models and human tissue to compare sequential versus simultaneous administration, building computational tumor models and clinical trial concepts. ISB president Dr. Jim Heath will lead the program.IsbscienceISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and ImmunotherapiesThe National Cancer Institute awarded the Institute for Systems Biology a $13 million, five-year grant to lead a collaborative cancer center focused on studying sequential combinations of targeted inhibitors and immunotherapies. The ST-Analytics program aims to determine if administering these treatments in specific sequences yields greater patient benefit than simultaneous use or monotherapies. ISB will collaborate with UCLA and Yale to develop computational models and clinical trial concepts for optimizing therapy timing.